Inherited primary renal tubular hypokalemic alkalosis: A review of Gitelman and Bartter syndromes

American Journal of the Medical Sciences

Volumn 322, Issue 6, 2001, Pages 316-332

  Shaer, Andrea J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Bartter syndrome; Gitelman syndrome; Hypokalemia; Metabolic alkalosis

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CHLORIDE CHANNEL; ION CHANNEL; MEMBRANE PROTEIN; POTASSIUM CHANNEL; SODIUM CHLORIDE TRANSPORTER; SODIUM POTASSIUM CHLORIDE TRANSPORTER; UNCLASSIFIED DRUG;

BARTTER SYNDROME; CONFERENCE PAPER; ELECTROLYTE DISTURBANCE; ELECTROLYTE TRANSPORT; FAILURE TO THRIVE; GENE MUTATION; GITELMAN SYNDROME; GROWTH RETARDATION; HYDRAMNIOS; HYPERCALCIURIA; HYPOKALEMIA; HYPOKALEMIC ALKALOSIS; KIDNEY CALCIFICATION; METABOLIC ALKALOSIS; MOLECULAR GENETICS; MUSCULOSKELETAL DISEASE; PATHOPHYSIOLOGY; PREMATURE LABOR;

EID: 0035208413     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200112000-00004     Document Type: Conference Paper

References (168)

1. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome
2. A new familial disorder characterized by hypokalemia and hypomagnesemia
3. Association of a mutation in thiazide-sensitive Na-Cl cotransporter with familial Gitelman's syndrome
4. Familial hypokalemia-hypomagnesemia or Gitelman's syndrome: A further case
5. Novel mutations in the thiazide-sensitive NaCl co-transporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain
6. Novel mutations in thiazide-sensitive Na-Cl cotransporter gene of patients with Gitelman's syndrome
7. Genetic heterogeneity in tubular hypomagnesemia-hypokalemia with hypocalciuria (Gitelman's syndrome)
8. Gitelman disease associated with growth hormone deficiency, disturbances in vasopressin secretion and empty sella: A new hereditary renal tubular-pituitary syndrome?
9. Bartter's syndrome: A review of 28 patients followed for 10 years
10. Acute muscular paralysis in an adult with subclinical Bartter's syndrome associated with gentamicin administration
11. Does magnesium play a role in the hypokalemia of Bartter's syndrome?
12. Renal magnesium wasting in Bartter's syndrome
13. Familial hypokalemia/hypomagnesemia and chondrocalcinosis
14. Asymptomatic Bartter's syndrome
15. Variant of Bartter's syndrome with a distal tubular rather than loop of Henle defect
16. Long-term evolution and growth patterns in a family with Bartter's syndrome
17. Bartter's syndrome: The unsolved puzzle
18. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes
19. Bartter syndrome and its neonatal variant
20. Bartter syndrome: Unraveling the pathophysiologic enigma
21. Gitelman's variant of Bartter's syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl co-transporter
22. Linkage of Gitelman syndrome to the thiazide-sensitive sodium-chloride cotransporter gene with identification of mutations in Dutch families
23. Novel molecular variants of the Na-Cl co-transporter gene are responsible for Gitelman syndrome
24. Peripheral blood mononuclear cells express mutated NCCT mRNA in Gitelman's syndrome: Evidence for abnormal thiazide-sensitive NaCl cotransport
25. Gitelman's syndrome (Bartter's variant) maps to the thiazide-sensitive cotransporter gene locus on chromosome 16q13 in a large kindred
26. Gitelman's syndrome is genetically distinct from other forms of Bartter's syndrome
27. Bartter's syndrome, hypokalemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl co-transporter NKCC2
28. Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome
29. A common NKCC2 mutation in Costa Rican Bartter's syndrome patients: Evidence for a founder effect
30. Phenotypic variability in Bartter syndrome type 1
31. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K channel, ROMK
32. Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: Evidence for genetic heterogeneity
33. Two novel mutations in the gene for Kir 1.1 (ROMK) in neonatal Bartter syndrome
34. Mutations in the ROMK gene in antenatal barter syndrome are associated with impaired K channel function
35. Large deletion of the 5′ end of the ROMK1 gene causes antenatal Bartter syndrome
36. A hyperprostaglandin E syndrome mutation in Kir1.1 (Renal outer medullary potassium) channels reveals a crucial residue for channel function in Kir1.3 channels
37. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III
38. A founder CLCNKB mutation causes type III Bartter's syndrome in Spain
39. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome
40. Liddle's syndrome: Heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel
41. Hypertension caused by a truncated epithelial sodium channel subunit: Genetic heterogeneity of Liddle syndrome
42. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalemic acidosis, pseudohypoaldosteronism type 1
43. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I
44. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy
45. Molecular mechanisms of human hypertension
46. Genetic disorders of renal electrolyte transport
47. Hyperplasia of the juxtaglomerular complex with secondary aldosteronism without hypertension (Bartter's syndrome)
48. Bartter's syndrome: An autosomal recessive disorder?
49. Chronic hypokalemia of adults: Gitelman's syndrome is frequent but classical Bartter's syndrome is rare
50. pH gating of ROMK (Kir1.1) channels: Control by an Arg-Lys-Arg Triad disrupted in antenatal Bartter syndrome
51. Endothelin and vascular reactivity in Bartter's syndrome
52. Electrocardiographic findings and frequency of arrhythmias in Bartter's syndrome
53. Growth characteristics and factors influencing growth in Bartter's syndrome
54. Growth characteristics in patients with Bartter's syndrome
55. Bartter's syndrome
56. The pathogenetic spectrum of Bartter's syndrome
57. Hypercalciuria with Bartter syndrome: Evidence for an abnormality of vitamin D metabolism
58. Bartter syndrome in two siblings. Antenatal and neonatal observations
59. Long-term use of propanolol, ibuprofen, and spironolactone in the management of Bartters syndrome
60. Chronic hypokalemia with growth retardation, normotensive hyperrenin-hyperaldosteronism (Bartter's syndrome), and hypercalciuria
61. Potassium-losing nephropathy of childhood
62. Inheritance of Bartter syndrome
63. Bartter syndrome: Typical facies and normal plasma volume
64. A variant of Bartter's syndrome
65. Congenital hypokalemia with hypercalciuria in preterm infants: A hyperprostaglandinuric tubular syndrome different from Bartter syndrome
66. Case studies of siblings with juxtaglomerular hyperplasia and secondary aldosteronism associated with severe azotemia and renal rickets - Bartter's syndrome or disease?
67. Prenatal diagnosis of Bartter syndrome
68. Infantile variant of Bartter syndrome and sensorineural deafness: A new autosomal recessive disorder
69. Bartter syndrome in Costa Rica: A description of 20 cases
70. Linkage of infantile Bartter syndrome with sensorineural deafness to chromosome 1p
71. Antenatal Bartter syndrome with sensorineural deafness: Refinement of the locus on chromosome 1p31
72. Impaired response to furosemide in hyperprostaglandin E syndrome: Evidence for a tubular defect in the loop of Henle
73. Neonatal Bartter syndrome: Spontaneous resolution of all signs and symptoms
74. Mutations in the Na-Cl cotransporter reduce blood pressure in humans
75. Evidence for disturbed regulation of calcitropic hormone metabolism in Gitelman syndrome
76. Magnesium deficiency: Pathophysiologic and clinical overview
77. Acute renal failure due to hypokalemic rhabdomyolysis in Gitelman's syndrome
78. Possible discrimination of Gitelman's syndrome from Bartter's syndrome by renal clearance study: Report of two cases
79. Gitelman syndrome comes of age
80. Gitelman's syndrome revisited: An evaluation of symptoms and health-related quality of life
81. A case of Gitelman's syndrome with chondrocalcinosis
82. Chondrocalcinosis and Gitelman's syndrome. A new association?
83. Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolones-induced arthropathy
84. Sclerochoroidal calcification associated with Gitelman syndrome
85. Choroidal calcification in Bartter syndrome
86. Bartter syndrome revisited
87. Bartter and related syndromes: The puzzle is almost solved
88. Phenotypic expression of Gitelman's syndrome heterozygotes
89. Maternal Bartter's syndrome and pregnancy
90. Renal tubular function in children and adolescents with Gitelman's syndrome, the hypocalciuric variant of Bartter's syndrome
91. Pseudo-Bartter's syndrome from surreptitious diuretic intake: Differential diagnosis with true Bartter's syndrome
92. Suppressed diluting segment reabsorption in Bartter's syndrome: Studies in 1 patient and synthesis of literature data
93. Bartter's syndrome due to a defect in salt reabsorption in the distal convoluted tubule
94. Renal handling of water and sodium in infancy and childhood: A study using clearance methods during hypotonic saline diuresis
95. Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of Henle as a proximal cause of Bartter's syndrome
96. - by the thiazide-inhibitable transporter of the distal convoluted tubule in Gitelman's syndrome
97. Familial hypokalemia-hypomagnesemia (Gitelman's syndrome)
98. 2 in Gitelman's syndrome, the hypocalciuric variant of Bartter's syndrome
99. Bartter's syndrome: Urinary prostaglandin E-like material and kallikrein; indomethacin effects
100. Bartter's syndrome: A disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis
101. Role of prostaglandins in the pathogenesis of Bartter's syndrome
102. Regulation of urinary prostaglandins in Bartter's syndrome
103. Bartter's syndrome with hyperplasia of renomedullary cells: Successful treatment with indomethacin
104. Prostaglandins and Bartter's syndrome
105. A circulating inhibitor of platelet aggregation in Bartter's syndrome
106. A defect in platelet aggregation in Bartter's syndrome
107. Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency
108. Evidence for parathyroid failure in magnesium deficiency
109. Inactivating mutations in the Na-Cl co-transporter is associated with high bone density
110. Calcium kinetics in the hyperprostaglandin E syndrome
111. Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndrome
112. Secondary hyperparathyroidism and bone disease in infants receiving long-term furosemide therapy
113. Renal calcifications: A complication of long-term furosemide therapy in preterm infants
114. Long term follow-up of a patient with Gitelman's syndrome
115. Evidence that potassium deficiency induces growth retardation through reduced circulating levels of growth hormone and insulin-like growth factor I
116. Bartter's syndrome. A report of four cases, including three in one sibship, with comparative histologic evaluation of the juxtaglomerular apparatuses and glomeruli
117. Bartter's syndrome with impairment of growth hormone secretion
118. Recombinant human growth hormone and Gitelman's syndrome
119. Bartter's syndrome, nephrocalcinosis and renal insufficiency
120. Non-steroidal anti-inflammatory drug-associated nephrotoxicity in Bartter syndrome
121. Association of Gitelman's syndrome and focal glomerulosclerosis
122. Bartter syndrome and focal segmental glomerulosclerosis: A possible link between two diseases
123. Reversal of Bartter's syndrome by renal transplantation in a child with focal, segmental glomerular sclerosis
124. Bartter's syndrome and erythrocytosis
125. The pathogenesis of Bartter's syndrome: Functional and histologic studies
126. Hypokalemic alkalosis, hyperreninemia, aldosteronism, normal blood pressure and absence of juxtaglomerular apparatus hyperplasia: A variant of Bartter;s syndrome or a new syndrome of renal alkalosis
127. Familial hypokalemia associated with renal interstitial fibrosis
128. Marked reduction of Tamm-Horsfall protein synthesis in hyperprostaglandin E syndrome
129. Surreptitious diuretic ingestion and pseudo-Bartter's syndrome
130. Electrolyte disturbances and cardiac failure with hypomagnesemia in anorexia nervosa
131. Chloride-resistant metabolic alkalosis in an adult with congenital chloride diarrhea
132. Pseudo-Bartter's syndrome in cystic fibrosis
133. + secretory defect
134. Bartter's syndrome: New insights into pathogenesis and treatment
135. Angiotensin II type 1 receptor gene abnormality in a patient with Bartter's syndrome
136. Captopril and Bartter's syndrome
137. Bartter's syndrome and the atrial natriuretic factor gene
138. - and cyclic guanosine monophosphate levels in patients with Bartter's syndrome: Relationship to vascular reactivity
139. A sibship with Bartter's syndrome: Failure of total adrenalectomy to correct the potassium wasting
140. The hemodynamic effects of the potassium deficiency in the dog
141. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition
142. Prostaglandins and other arachidonic acid metabolites in the kidney
143. Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle
144. Arachidonic acid inhibits activity of cloned renal K+ channel, ROMK1
145. Paracellin-1, a renal tight junction protein required for paracellular Mg resorption
146. Calcium transport through the luminal membrane of the distal tubule. I. Interrelationship with sodium
147. Renal magnesium handling: New insights in understanding old problems
148. Hypomagnesemia of hereditary renal origin
149. Amiloride in Bartter's syndrome
150. Juxtaglomerular cell hyperplasia and secondary hyperaldosteronism (Bartter's syndrome): A reevaluation of the pathophysiology
151. Nephropathologic characteristics of a woman with Bartter's syndrome after prolonged treatment with spironolactone
152. Growth from birth to adulthood in a patient with the neonatal form of Bartter syndrome
153. Treatment of Bartter's syndrome with indomethacin
154. Bartter syndrome in a neonate: Early treatment with indomethacin
155. Pre-pubertal growth in the hyperprostaglandin E syndrome
156. Neonatal Bartter's syndrome, indomethacin and necrotizing enterocolitis
157. Correction of hypokalemia in Bartter's syndrome by enalapril
158. Effect of captopril on blood pressure, renal function, the electrolyte balance and the renin-angiotensin system in Bartter's syndrome
159. Long-term captopril therapy of 3 sisters with Bartter's syndrome (Italian)
160. The use of captopril in Bartter's syndrome
161. Long-term enalapril therapy in Bartter's syndrome
162. Total body potassium in Bartter's syndrome before and during treatment with enalapril
163. Captopril treatment in Bartter's syndrome
164. Some observations on the pathogenesis of Bartter's syndrome
165. Propanolol in Bartter's syndrome
166. Magnesium deficiency: Pathophysiology and clinical overview
167. Magnesium supplementation in Gitelman syndrome
168. Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome